Notably, Hes and Nar treatment antagonized the protective effect of BMSCs on MM cells (Fig. 2E), suggesting that these compounds have the potential to disrupt the microenvironmental interactions prompting MM cell survival. This evidence concerns the gene RRBP1 and Miyoshi myopathy.